← The Wire
PMVPNasdaq
PMV Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1699382
PMV Pharmaceuticals develops precision oncology therapies targeting p53 mutations to eliminate cancer cells
$59M
Market cap
$1.29
Last close
+8.4%
1D
+13.2%
5D
543K
Volume
Price · last 39 sessions-7.9%
May 4L $1.05 · H $1.45Jun 29
98
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 5, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 20268-KResults of OperationsMar 6, 202610-K10-KMar 6, 2026SC 13D/ASC 13D/AMar 4, 202610-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KReg FD Disclosure · Company UpdateSep 10, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KShareholder VoteJun 9, 202510-Q10-QMay 9, 20258-KResults of OperationsMay 9, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 202510-K10-KMar 3, 20258-KResults of OperationsMar 3, 2025SC 13GSC 13GDec 12, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 202410-Q10-QAug 8, 20248-KAgreement Terminated · Results of OperationsAug 8, 20248-KShareholder VoteJun 7, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 24, 2024DEF 14ADEF 14AApr 24, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 29, 2024SC 13GSC 13GFeb 14, 20248-KExit / Disposal Costs · Reg FD DisclosureJan 18, 20248-KExecutive Change · Reg FD DisclosureJan 5, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KCompany UpdateOct 12, 20238-KReg FD DisclosureOct 11, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KShareholder VoteJun 9, 2023SC 13GSC 13GMay 19, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEFA14ADEFA14AApr 28, 20238-KBylaw AmendmentApr 28, 2023DEF 14ADEF14AApr 28, 202310-K10-KMar 1, 20238-KResults of OperationsMar 1, 202310-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KExecutive Change · Reg FD DisclosureNov 4, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 2022SC 13GSC 13GJul 11, 2022SC 13GPMV PHARMACEUTICALS, INC.Jun 17, 20228-KReg FD DisclosureJun 8, 20228-KShareholder VoteJun 6, 20228-KReg FD DisclosureMay 26, 202210-Q10-QMay 10, 20228-KResults of OperationsMay 10, 2022DEFA14ADEFA14AApr 22, 2022DEF 14ADEF 14AApr 22, 202210-K10-KMar 1, 20228-KResults of OperationsMar 1, 2022SC 13GPMV PHARMACEUTICALS, INC.Feb 14, 2022SC 13GSCHEDULE 13GFeb 10, 2022SC 13GSC 13GFeb 4, 2022SC 13GFILING PMV PHARMACEUTICALS, INC.Jan 26, 2022SC 13GCOWEN FINANCIAL PRODUCTS LLCJan 19, 20228-KExecutive Change · Reg FD DisclosureJan 6, 202210-Q10-QNov 12, 20218-KResults of OperationsNov 12, 20218-KMaterial AgreementOct 5, 202110-Q10-QAug 13, 20218-KResults of OperationsAug 13, 20218-KShareholder VoteJun 7, 202110-Q10-QMay 14, 20218-KResults of OperationsMay 14, 2021
Insider Activity
In the 90 days to Oct 23, 2025: 1 sold $1.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2025 | Orbimed Capital Gp V LlcTenPercentOwner | Sell | 1,000,000 | $1.52 | $1.5M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance